(Q40774319)

English

A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

hydroxycarbamide

1 reference

based on heuristic

inferred from title

author name string

B Anger

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

F Porzsolt

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

R Leichtle

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

B Heinze

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

C Bartram

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

H Heimpel

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 1989

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

275-278

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2736308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2736308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical investigation of human alpha interferon in chronic myelogenous leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2736308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/2736308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[alpha 2-interferon: preliminary treatment results in chronic myeloid leukemia]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2736308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxyurea versus busulfan in the treatment of chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2736308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blast crisis of Philadelphia chromosome-positive chronic myelocytic leukemia (CML). Treatment results of 69 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2736308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of chronic myelogenous leukemia: chemotherapy and interferons

1 reference

https://pubmed.ncbi.nlm.nih.gov/2736308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of chronic myelogenous leukemia with recombinant interferon-gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2736308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/2736308

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00320165

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40774319&oldid=1906966762"